CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses
Research and development	$ 25,237	$ 26,135
General and administrative	7,525	8,178
Total operating expenses	32,762	34,313
Loss from operations	(32,762)	(34,313)
Other income, net:
Interest income	3,246	3,465
Other (expense) income, net	(2)	33
Total other income, net	3,244	3,498
Net loss	(29,518)	(30,815)
Other comprehensive loss:
Net unrealized (loss) gain on investments	(135)	505
Comprehensive loss	$ (29,653)	$ (30,310)
Net loss per share, basic	$ (0.58)	$ (0.63)
Net loss per share, diluted	$ (0.58)	$ (0.63)
Weighted average shares used to compute net loss per share, basic	50,682,469	48,921,326
Weighted average shares used to compute net loss per share, diluted	50,682,469	48,921,326